IPCX vs HVII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

IPCX

44.8
AI Score
VS
HVII Wins

HVII

57.9
AI Score

Investment Advisor Scores

IPCX

45score
Recommendation
HOLD

HVII

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IPCX HVII Winner
Net Income 575,611 498,416 HVII
Operating Income -1.10M -6.53M HVII
ROE -5.7% -3.6% IPCX
ROA 0.3% 0.2% HVII
Total Assets 199.27M 261.13M IPCX
Cash 323,217 1.13M IPCX
Current Ratio 6.82 2.84 HVII

Relative Price Performance (Last 90 Days)

IPCX 1M: -56.9% · 3M: -56.8% HVII 1M: +0.4% · 3M: +1.0%

Current Technical Phase

IPCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.7%), weak momentum, RSI 13

RSI (14): 12.9 · Price: $4.45

HVII

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.8 · Price: $10.49

Fundamentals Snapshot

Metric IPCX HVII
Market Cap
Forward P/E -18.1 -65.6
Trailing P/E 99.4 87.4
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS 0.10 0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HVII is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.